查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1302892

花生四烯酸市場——2023年至2028年預測

Arachidonic Acid Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計在預測期內，全球花生四烯酸市場將以 5.15% 的複合年增長率增長。

花生四烯酸是一種有助於嬰兒大腦發育的脂肪酸。花生四烯酸 (ARA) 是生物細胞膜的重要組成部分，為所有細胞提供正常運作所需的流動性和靈活性，尤其是免疫系統、骨骼肌和神經系統中的細胞。亞油酸來源於食物或亞油酸通過去飽和和鏈伸長而得。離子通道、受體和□都受到游離 ARA 激活和抑制能力的影響。

重要的 omega-6 脂肪酸之一是花生四烯酸。它被認為是一種必需酸，因為它保留在細胞膜內，並發出響應破壞事件的再生變化信號。由於體內缺乏天然花生四烯酸，花生四烯酸必須通過注射劑、糖漿和片劑單獨服用。ARA的主要原料是玉米、葡萄糖、大豆、酵母。

隨著消費者健康意識的增強，營養補充劑中對 ARA 的需求不斷增加。隨著賽車和馬拉松等戶外運動賽事越來越受歡迎，身體受傷的可能性預計會增加，並預計將推動市場覆蓋率和創收的上升。嬰兒配方奶粉的普及率不斷上升，運動營養品的使用頻率也不斷增加，有助於市場擴張。

增加嬰兒配方奶粉中花生四烯酸的使用

由於技術的快速進步和領先公司的新專利申請，在預測期內，嬰兒配方奶粉中花生四烯酸的使用可能會增加。嬰兒需要 omega-6 脂肪酸，因為他們無法合成所需的量。因此，在嬰兒食品中添加ARA起到了供給必需脂肪酸的作用。幫助發育中的嬰兒大腦合成細胞膜的主要成分是 DHA 和花生四烯酸 (ARA)（一種 20 碳脂肪酸）。母乳中 DHA 和 ARA 的含量因國家而異，具體取決於母親的飲食。

田徑運動是 ARA 需求量很大的一個重要領域。

花生四烯酸在田徑界正在蓬勃發展。ARA 補充劑也在神經病學、肝病學、心髒病學和營養學領域進行研究。儘管花生四烯酸可以控制炎症，但人們仍擔心這些補充劑的相關風險。受過訓練的男性的瘦體重指數、全身力量和峰值功率都可以通過 ARA 補充劑得到改善。

富含 ARA 的油的供應是一個重要的需求驅動因素。

從真菌高山被孢黴中提取的富含 ARA 的油的使用是眾所周知的，這種成分長期以來一直用於嬰兒配方奶粉和後續牛奶中。根據歐盟法律，從高山被孢黴中提取的油目前被允許用於嬰兒配方奶粉、後續牛奶和新生兒醫療飲食。德國BASF和中國Hubei Fuxing Biotechnology是利用高山被Mortierella Alpina菌生產富含 ARA 的油的領先公司。

預計北美將成為預測期內的主要市場。

預計北美將成為花生四烯酸在食品應用中的最大市場，其次是歐洲和亞太地區。歐盟監管環境支持本地市場的擴張。嬰兒配方奶粉中 ARA 的需求受到眾多公司的存在、積極的研發活動以及在嬰兒配方奶粉和運動營養中使用 ARA 的大量新專利以及北美（尤其是墨西哥）出生率不斷上升的推動。目前利用 ARA 治療糖尿病的趨勢預計將支持北美國家市場的進一步擴張。

市場趨勢：

  • 2022年10月，CABIO研發中心投資項目在武漢光谷啟動。基於上述投資舉措，與CABIO Biotech（武漢）、Hubei Yangtze Science Innovation Service合作啟動了武漢合成生物創新中心項目。
  • 2022 年 7 月，Continental Grain和Cargill收購了Sanderson Farm。作為交易的一部分，兩家公司合併了Sanderson Farm和Wayne Farm，創建了一家新的家禽公司。

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場細分
  • 貨幣
  • 先決條件
  • 基準年和預測年的時間表

第二章研究方法論

  • 調查數據
  • 先決條件

第三章執行摘要

  • 調查亮點

第四章市場動態

  • 市場驅動力
  • 市場製約因素
  • 波特五力分析
  • 行業價值鏈分析

第五章全球花生四烯酸市場：按來源分類

  • 介紹
  • 動物
  • 植物

6.全球花生四烯酸市場，按形式

  • 介紹
  • 烘乾
  • 液體

第七章全球花生四烯酸市場：按應用分類

  • 介紹
  • 食品與飲品
    • 嬰幼兒配方奶粉
    • 膳食補充劑
  • 藥品

第八章全球花生四烯酸市場：按地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印度尼西亞
    • 泰國
    • 其他

第九章競爭格局與分析

  • 主要公司及戰略分析
  • 初創企業和市場盈利能力
  • 合併、收購、協議與合作
  • 供應商競爭力矩陣

第十章公司簡介

  • Cargill. Inc
  • Cabio Biotech（Wuhan）Co., Ltd
  • Cayman Chemicals
  • Koninklijke DSM N.V.
  • Merck Group
  • Suntory Beverage & Food Ltd.
  • Cayman Chemical Company
  • Avanti Polar Lipids, Inc.
簡介目錄
Product Code: KSI061615437

The global arachidonic acid market is estimated to grow at a CAGR of 5.15% during the forecast period.

Arachidonic is a fatty acid that helps in a baby's developing brain. Arachidonic acid (ARA) is a crucial aspect of biological cell membranes because it gives them the fluidity and flexibility necessary for all cells to function properly, especially those in the immune system, skeletal muscle, and neurological systems. It comes from food or linoleic acid undergoing de-saturation and chain elongation. Ion channels, receptors, and enzymes are all affected by free ARA's ability to both activate and inhibit them.

One of the important Omega-6 fatty acids is arachidonic acid. It is regarded as an essential acid. because it is kept inside cell membranes and guides signals of regenerative changes in response to damaging events. A separate intake of arachidonic acid in injections, syrups, or pills is required due to the body's lack of natural arachidonic acid. The main ingredients used to make ARA are, among others, maize, glucose, soy, and yeast.

There is a rising demand for ARA in dietary supplements as consumers become more health conscious. The probability of physical injuries is anticipated to rise with the popularity of outdoor athletic events like car racing and marathons, which are projected to drive the market in terms of rising application rates and generating revenue. Infant feeding formula penetration is rising, and sports nutrition is also being used more frequently, contributing to the market's expansion.

Increased use of arachidonic acid in infant formula

The fast technical improvements and new patents filed by the major market players will likely lead to a rise in the use of arachidonic acid in baby feeding during the forecast period. Babies require omega-6 fatty acids since they cannot synthesize the necessary quantity. As a result, the inclusion of ARA in baby food serves to supply the required fatty acids. The main elements that aid in synthesizing cell membranes in developing infants' brains are DHA and arachidonic acid (ARA), a 20-carbon fatty acid. Depending on a mother's diet, the amount of DHA and ARA in breast milk varies greatly between nations.

Athletics is a key area for the growing demand for ARA.

Arachidonic acid is growing rapidly in the world of athletics. Research on ARA supplements has also been conducted in neurology, hepatology, cardiology, and nutrition. Arachidonic acid regulates inflammation, although there are concerns regarding the risks associated with these supplements. The lean BMI, overall strength, and peak power of trained men may all be improved with ARA supplementation.

Utilization of ARA-rich oils is a significant demand driver.

The use of ARA-rich oils obtained from the fungus Mortierella Alpina is well known, and the ingredient has long been used in infants and subsequent formulae. According to EU law, oil extracted from Mortierella Alpina is now allowed in infant formula, follow-on formula, and meals for medical purposes for newborns. The German company BASF and the Chinese company Hubei Fuxing Biotechnology are the leading firms producing ARA-rich oils from the fungus Mortierella Alpina.

North America is projected to be the prominent market throughout the forecast period.

North America is anticipated to be the largest market for arachidonic acid in food applications, second in Europe and Asia Pacific. The regulatory environment in the EU has helped the local market expand. The demand for ARA in infant formula is growing due to the presence of numerous companies, the intense R&D activities carried out with numerous new patents using ARA for infant formula, as well as sports nutrition, and the rising fertility rate in North America, particularly in Mexico. The current trend of utilizing ARA to treat diabetes is anticipated to aid in expanding the market in additional North American nations.

Market Developments:

  • In October 2022, the CABIO R&D Centre investment project started in Wuhan Optical Valley. The Wuhan Synthetic Biology Innovation Centre project was launched based on the aforementioned investment initiative, a collaboration between CABIO Biotech (Wuhan) and Hubei Yangtze Science Innovation Service.
  • In July 2022, Continental Grain and Cargill bought Sanderson Farms. Both have merged Sanderson Farms and Wayne Farms as part of the transaction to launch a new chicken company.

Market Segmentation:

By Source

  • Animal
  • Plant

By Form

  • Dry
  • Liquid

By Application

  • Food and Beverage
  • Infant Formula
  • Dietary Supplements
  • Pharmaceuticals

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL ARACHIDONIC ACID MARKET, BY SOURCE

  • 5.1. Introduction
  • 5.2. Animal
  • 5.3. Plant

6. GLOBAL ARACHIDONIC ACID MARKET, BY FORM

  • 6.1. Introduction
  • 6.2. Dry
  • 6.3. Liquid

7. GLOBAL ARACHIDONIC ACID MARKET, BY APPLICATION

  • 7.1. Introduction
  • 7.2. Food and Beverage
    • 7.2.1. Infant Formula
    • 7.2.2. Dietary Supplements
  • 7.3. Pharmaceuticals

8. GLOBAL ARACHIDONIC ACID MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. Cargill. Inc
  • 10.2. Cabio Biotech (Wuhan)Co., Ltd
  • 10.3. Cayman Chemicals
  • 10.4. Koninklijke DSM N.V.
  • 10.5. Merck Group
  • 10.6. Suntory Beverage & Food Ltd.
  • 10.7. Cayman Chemical Company
  • 10.8. Avanti Polar Lipids, Inc.